Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04140487 |
|---|---|
| Brief Title: | Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm |
| First Submitted : | August 19, 2019 |
| First Submitted that Met QC Criteria : | October 24, 2019 |
| First Posted : | October 28, 2019 |
| Last Update Submitted that Met QC Criteria : | March 14, 2024 |
| Last Update Posted : | March 15, 2024 |